VEGFR-1 antagonists and PlGF have great therapeutic potential

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1354, 2002-01, pp. : 7-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potential therapeutic targets for neurokinin-1 receptor antagonists

By Duffy Ruth A  

Expert Opinion on Emerging Drugs, Vol. 9, Iss. 1, 2004-05 ,pp. : 9-21

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic potential of protease-activated receptor-1 antagonists

By Derian Claudia K   Maryanoff Bruce E   Zhang Han-Cheng   Andrade-Gordon Patricia  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 2, 2003-02 ,pp. : 209-221

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic potential of melanin-concentrating hormone-1 receptor antagonists for the treatment of obesity

By Kowalski Timothy J   McBriar Mark D  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 9, 2004-09 ,pp. : 1113-1122

Informa Healthcare

Access to resources Recommend Favorite

CB1 Cannabinoid Antagonists: Structure-Activity Relationships and Potential Therapeutic Applications

By  

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 3, 2008-02 ,pp. : 205-230

Bentham Science Publishers

Access to resources Recommend Favorite

Do vasopressin receptor type 2 antagonists have therapeutic potential in polycystic kidney diseases?

By Doggrell Sheila A  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 4, 2004-04 ,pp. : 431-434

Informa Healthcare

Access to resources Recommend Favorite